Write in a clean editor, then format for EJC Skin Cancer in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
EJC Skin Cancer is a peer-reviewed journal published by Elsevier, covering Cutaneous Melanoma Detection and Management, Nonmelanoma Skin Cancer Studies, Melanoma and MAPK Pathways.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, EJC Skin Cancer 12 (2023) 45–58.
Formats any DOI in EJC Skin Cancer style. No sign-up. |
| Publishes research in | Cutaneous Melanoma Detection and Management Nonmelanoma Skin Cancer Studies Melanoma and MAPK Pathways Cancer Immunotherapy and Biomarkers Cancer and Skin Lesions |
| ISSN | 2772-6118 |
| Citation impact (2-yr) | 0.19 |
| h-index | 6 |
| i10-index | 4 |
| Total citations | 285 |
| Open access | Yes |
| Top institutions publishing here | Hospital Clínic de Barcelona |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BackgroundMohs micrographic surgery (MMS) is the preferred surgical approach for high-risk basal cell carcinoma (BCC). Pre-surgical tumor margins delineation with line field confocal optical coherence tomography (LC-OCT) is expected to reduce MMS stages number.Objectiveto investigate the effectiveness of LC-OCT preoperative evaluation of high-risk BCC margins in reducing the number of MMS stages to achieve tumor…
Adjuvant (ADJ) systemic therapy has transformed melanoma treatment during the past decade. There are, however, still important unanswered questions that lead to debates on the utility and place of ADJ therapy for melanoma. When ADJ trials are reported, they present a hazard ratio with a significant P-value. This illustrates the relative benefit of the ADJ…
Adnexal cancers of the skin constitute a heterogeneous group of malignant tumors with specific pathologic and biological differences. This review aims to provide clinicians with a summary of how to manage the diagnosis, staging, and treatment of cutaneous adnexal cancer patients. In clinical practice, the complexity of this clinical and pathological heterogeneity is partially mitigated…
BackgroundNeoadjuvant immune-checkpoint inhibition (neoICI) with ipilimumab and nivolumab has shown high pathologic response rates as well as a long-lasting relapse-free survival in stage III melanoma patients. However, safety and efficacy data from real-world patients is very limited.MethodsStage IIIB-IV (M1a) melanoma patients with macroscopic nodal metastases with or without synchronous non-nodal lesions received combined neoICI with…
Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma”…
